SA
GMAB logo
Genmab A/S(GMAB)
Closing price · checked 8:25 PM ETAbout this dataData status
$50.60▼-0.75 (-1.46%)
Extended:$50.02-0.58 (-1.15%)· 8:25 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Genmab A/S (GMAB)

R&D Expenses

$1.88B

TTM · Period ending: · USD

GMAB logo

GMAB R&D Expenses

Latest reported$1.88B
GMAB R&D Expenses ($396.23M → $1.88B)
Powered by
High-resolution chart · PNG

What is r&d expenses?

Research and development spending.

GMAB r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Genmab A/S R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)Change
1,560,229,544−83.99%
9,748,000,000+27.76%
7,630,000,000+37.18%
5,562,000,000+33.03%
4,181,000,000+33.28%
3,137,000,000+31.48%
2,386,000,000+66.72%
1,431,159,000+63.70%
874,278,000+32.29%
660,876,000+35.52%
487,656,000−3.56%
505,679,000−4.15%
527,576,000−1.70%
536,702,000—
0—
0−100.00%
935,361,000−34.26%
1,422,770,000+130.03%
618,503,000+71.83%
359,953,000+18.37%
304,103,000−18.54%
373,330,000+7.90%
345,983,000−12.68%
396,234,000—

Frequently asked questions: GMAB r&d expenses

What is Genmab A/S (GMAB)'s current r&d expenses?

Genmab A/S (GMAB)'s latest reported r&d expenses (TTM) is $1.88B as of Sep 30, 2026. Research and development spending.

How much historical r&d expenses data is available for GMAB?

Stock Alarm Pro provides 24 dated annual fiscal periods observations for Genmab A/S (GMAB)'s r&d expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare GMAB's r&d expenses to peers or set an alert?

You can open GMAB's r&d expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on GMAB delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.